Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luna Liu

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Analytical Biochemistry|January 11, 2011
Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometryKeyang Xu, Luna Liu, Ola M Saad, et al.
Iscience|October 16, 2023
Dominant-negative HNF1α mutant promotes liver steatosis and inflammation by regulating hepatic complement factor DMoke Liu, Luna Liu, Honglin Guo, et al.
The AAPS Journal|September 20, 2022
Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple MyelomaHao Cai, Satoko Kakiuchi-Kiyota, Robert Hendricks, et al.
Bioanalysis|November 9, 2019
Immunoaffinity LC-MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serumLuna Liu, Yanqiu Liu, Lu Dai, et al.
Clinical and Molecular Hepatology|December 7, 2023
Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targetsYingzhou Shi, Hang Dong, Shiwei Sun, et al.
Life Sciences|July 22, 2025
Endoplasmic reticulum stress and autophagy as potential therapeutic targets in SERPINF1 mutation-induced type VI osteogenesis imperfectaYang Tian, Xinyu Chen, Shuoshuo Wei, et al.
Pharmaceutical Research|December 3, 2014
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug ConjugatesSiddharth Sukumaran, Kapil Gadkar, Crystal Zhang, et al.
Analytical Chemistry|April 22, 2017
High-Resolution Accurate-Mass Mass Spectrometry Enabling In-Depth Characterization of in Vivo Biotransformations for Intact Antibody-Drug ConjugatesJintang He, Dian Su, Carl Ng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 16, 2016
Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug ConjugatesDonglu Zhang, Shang-Fan Yu, Yong Ma, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Identification of orally-bioavailable antagonists of the TRPV4 ion-channelZhi-Liang Wei, Margaret T Nguyen, Donogh J R O'Mahony, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Analytical Biochemistry|January 11, 2011
Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometryKeyang Xu, Luna Liu, Ola M Saad, et al.
Iscience|October 16, 2023
Dominant-negative HNF1α mutant promotes liver steatosis and inflammation by regulating hepatic complement factor DMoke Liu, Luna Liu, Honglin Guo, et al.
The AAPS Journal|September 20, 2022
Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple MyelomaHao Cai, Satoko Kakiuchi-Kiyota, Robert Hendricks, et al.
Bioanalysis|November 9, 2019
Immunoaffinity LC-MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serumLuna Liu, Yanqiu Liu, Lu Dai, et al.
Clinical and Molecular Hepatology|December 7, 2023
Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targetsYingzhou Shi, Hang Dong, Shiwei Sun, et al.
Life Sciences|July 22, 2025
Endoplasmic reticulum stress and autophagy as potential therapeutic targets in SERPINF1 mutation-induced type VI osteogenesis imperfectaYang Tian, Xinyu Chen, Shuoshuo Wei, et al.
Pharmaceutical Research|December 3, 2014
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug ConjugatesSiddharth Sukumaran, Kapil Gadkar, Crystal Zhang, et al.
Analytical Chemistry|April 22, 2017
High-Resolution Accurate-Mass Mass Spectrometry Enabling In-Depth Characterization of in Vivo Biotransformations for Intact Antibody-Drug ConjugatesJintang He, Dian Su, Carl Ng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 16, 2016
Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug ConjugatesDonglu Zhang, Shang-Fan Yu, Yong Ma, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Identification of orally-bioavailable antagonists of the TRPV4 ion-channelZhi-Liang Wei, Margaret T Nguyen, Donogh J R O'Mahony, et al.
Pageof 6